Skip to main content

Main menu

  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Current Issue
    • Issue Archive
    • Blog
    • Collections
    • Podcast
  • TOPICS
    • Cognition and Behavior
    • Development
    • Disorders of the Nervous System
    • History, Teaching and Public Awareness
    • Integrative Systems
    • Neuronal Excitability
    • Novel Tools and Methods
    • Sensory and Motor Systems
  • ALERTS
  • FOR AUTHORS
  • ABOUT
    • Overview
    • Editorial Board
    • For the Media
    • Privacy Policy
    • Contact Us
    • Feedback
  • SUBMIT

User menu

Search

  • Advanced search
eNeuro
eNeuro

Advanced Search

 

  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Current Issue
    • Issue Archive
    • Blog
    • Collections
    • Podcast
  • TOPICS
    • Cognition and Behavior
    • Development
    • Disorders of the Nervous System
    • History, Teaching and Public Awareness
    • Integrative Systems
    • Neuronal Excitability
    • Novel Tools and Methods
    • Sensory and Motor Systems
  • ALERTS
  • FOR AUTHORS
  • ABOUT
    • Overview
    • Editorial Board
    • For the Media
    • Privacy Policy
    • Contact Us
    • Feedback
  • SUBMIT
PreviousNext
Research ArticleResearch Article: New Research, Development

Cannabinoid Receptor 1 Is Required for Neurodevelopment of Striosome-Dendron Bouquets

Jill R. Crittenden, Tomoko Yoshida, Samitha Venu, Ara Mahar and Ann M. Graybiel
eNeuro 31 March 2022, 9 (2) ENEURO.0318-21.2022; https://doi.org/10.1523/ENEURO.0318-21.2022
Jill R. Crittenden
1McGovern Institute for Brain Research, Massachusetts Institute of Technology, Cambridge, MA 02139
2Department of Brain and Cognitive Sciences, Massachusetts Institute of Technology, Cambridge, MA 02139
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Jill R. Crittenden
Tomoko Yoshida
1McGovern Institute for Brain Research, Massachusetts Institute of Technology, Cambridge, MA 02139
2Department of Brain and Cognitive Sciences, Massachusetts Institute of Technology, Cambridge, MA 02139
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Samitha Venu
1McGovern Institute for Brain Research, Massachusetts Institute of Technology, Cambridge, MA 02139
2Department of Brain and Cognitive Sciences, Massachusetts Institute of Technology, Cambridge, MA 02139
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ara Mahar
1McGovern Institute for Brain Research, Massachusetts Institute of Technology, Cambridge, MA 02139
2Department of Brain and Cognitive Sciences, Massachusetts Institute of Technology, Cambridge, MA 02139
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ann M. Graybiel
1McGovern Institute for Brain Research, Massachusetts Institute of Technology, Cambridge, MA 02139
2Department of Brain and Cognitive Sciences, Massachusetts Institute of Technology, Cambridge, MA 02139
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

DOI 
https://doi.org/10.1523/ENEURO.0318-21.2022
PubMed 
35361667
Published By 
Society for Neuroscience
History 
  • Received July 26, 2021
  • Revision received March 10, 2022
  • Accepted March 16, 2022
  • Published online March 31, 2022.
Copyright & Usage 
Copyright © 2022 Crittenden et al. This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license, which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed.

Author Information

  1. Jill R. Crittenden1,2,
  2. Tomoko Yoshida1,2,
  3. Samitha Venu1,2,
  4. Ara Mahar1,2 and
  5. Ann M. Graybiel1,2
  1. 1McGovern Institute for Brain Research, Massachusetts Institute of Technology, Cambridge, MA 02139
  2. 2Department of Brain and Cognitive Sciences, Massachusetts Institute of Technology, Cambridge, MA 02139
  1. Correspondence should be addressed to Ann M. Graybiel at graybiel{at}mit.edu.
View Full Text

Author contributions

  1. Author contributions: J.R.C. and A.M.G. designed research; J.R.C., T.Y., S.V., and A.M. performed research; J.R.C., T.Y., S.V., and A.M.G. analyzed data; J.R.C.and A.M.G. wrote the paper.

Disclosures

  • The authors declare no competing financial interests.

  • This work was supported by the Broderick Fund for Phytocannabinoid Research at Massachusetts Institute of Technology, the Saks Kavanaugh Foundation, the National Institutes of Health/National Institute of Mental Health Grant R01 MH060379, the Kristin R. Pressman and Jessica J. Pourian ‘13 Fund, Mr. Robert Buxton, and William N. & Bernice E. Bumpus Foundation.

Funding

  • Broderick Fund for Phytocannabinoid Research at MIT

  • Saks Kavanaugh Foundation

  • HHS | NIH | National Institute of Mental Health (NIMH)

    R01 MH060379
  • William N. & Bernice E. Bumpus Foundation

  • Kristin R. Pressman and Jessica J. Pourian ’13 Fund

  • Robert Buxton

Other Version

  • You are viewing the most recent version of this article.
  • previous version (March 31, 2022).

Online Impact

 

Article usage

Select a custom date range for the past year
E.g., 2026-01-23
to
E.g., 2026-01-23

Article usage: March 2022 to January 2026

AbstractFullPdf
Mar 202260024
Apr 2022722459388
May 20222326677
Jun 20221422854
Jul 2022411942
Aug 2022310126
Sep 20221110632
Oct 20221711439
Nov 2022209031
Dec 2022157411
Total 20228891557724
Jan 202388920
Feb 202318818
Mar 202349930
Apr 2023310116
May 202326918
Jun 20235929
Jul 2023810222
Aug 202377731
Sep 202358115
Oct 202319323
Nov 2023411224
Dec 2023911734
Total 2023571120260
Jan 2024311123
Feb 202498217
Mar 2024310625
Apr 2024944925
May 202449118
Jun 2024910020
Jul 2024610424
Aug 202469120
Sep 202478615
Oct 202498425
Nov 202459514
Dec 202498630
Total 2024791485256
Jan 202539824
Feb 202531149
Mar 2025510825
Apr 2025511325
May 202569518
Jun 2025611925
Jul 2025412824
Aug 2025713329
Sep 20251018925
Oct 2025811420
Nov 20251612414
Dec 2025813031
Total 2025811465269
Jan 202629020
Total 202629020
Total110857171529
Back to top

In this issue

eneuro: 9 (2)
eNeuro
Vol. 9, Issue 2
March/April 2022
  • Table of Contents
  • Index by author
  • Ed Board (PDF)
Email

Thank you for sharing this eNeuro article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Cannabinoid Receptor 1 Is Required for Neurodevelopment of Striosome-Dendron Bouquets
(Your Name) has forwarded a page to you from eNeuro
(Your Name) thought you would be interested in this article in eNeuro.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
View Full Page PDF
Citation Tools
Cannabinoid Receptor 1 Is Required for Neurodevelopment of Striosome-Dendron Bouquets
Jill R. Crittenden, Tomoko Yoshida, Samitha Venu, Ara Mahar, Ann M. Graybiel
eNeuro 31 March 2022, 9 (2) ENEURO.0318-21.2022; DOI: 10.1523/ENEURO.0318-21.2022

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Respond to this article
Share
Cannabinoid Receptor 1 Is Required for Neurodevelopment of Striosome-Dendron Bouquets
Jill R. Crittenden, Tomoko Yoshida, Samitha Venu, Ara Mahar, Ann M. Graybiel
eNeuro 31 March 2022, 9 (2) ENEURO.0318-21.2022; DOI: 10.1523/ENEURO.0318-21.2022
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Significance Statement
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
    • Synthesis
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Keywords

  • cannabinoid
  • CB1R
  • dopamine
  • striosome
  • striosome-dendron bouquet
  • striatum

Responses to this article

Respond to this article

Jump to comment:

No eLetters have been published for this article.

Related Articles

Cited By...

More in this TOC Section

Research Article: New Research

  • Bidirectional Cerebellar Control of Supra-Second Timing in Rats
  • Fast spiking interneurons autonomously generate fast gamma oscillations in the medial entorhinal cortex with excitation strength tuning ING–PING transitions
  • The serotonin 1B receptor modulates striatal activity differentially based on behavioral context
Show more Research Article: New Research

Development

  • Partial Deletion of Cxcl12 from Hippocampal Cajal–Retzius Cells Does Not Disrupt Dentate Gyrus Development or Neurobehaviors
  • Absence of Testes at Puberty Impacts Functional Development of Nigrostriatal But Not Mesoaccumbal Dopamine Terminals in a Wild-Derived Mouse
  • Anxiety-Associated Behaviors Following Ablation of Miro1 from Cortical Excitatory Neurons
Show more Development

Subjects

  • Development
  • Home
  • Alerts
  • Follow SFN on BlueSky
  • Visit Society for Neuroscience on Facebook
  • Follow Society for Neuroscience on Twitter
  • Follow Society for Neuroscience on LinkedIn
  • Visit Society for Neuroscience on Youtube
  • Follow our RSS feeds

Content

  • Early Release
  • Current Issue
  • Latest Articles
  • Issue Archive
  • Blog
  • Browse by Topic

Information

  • For Authors
  • For the Media

About

  • About the Journal
  • Editorial Board
  • Privacy Notice
  • Contact
  • Feedback
(eNeuro logo)
(SfN logo)

Copyright © 2026 by the Society for Neuroscience.
eNeuro eISSN: 2373-2822

The ideas and opinions expressed in eNeuro do not necessarily reflect those of SfN or the eNeuro Editorial Board. Publication of an advertisement or other product mention in eNeuro should not be construed as an endorsement of the manufacturer’s claims. SfN does not assume any responsibility for any injury and/or damage to persons or property arising from or related to any use of any material contained in eNeuro.